FR2565822B1 - Nouvelle forme galenique retard - Google Patents

Nouvelle forme galenique retard

Info

Publication number
FR2565822B1
FR2565822B1 FR858508850A FR8508850A FR2565822B1 FR 2565822 B1 FR2565822 B1 FR 2565822B1 FR 858508850 A FR858508850 A FR 858508850A FR 8508850 A FR8508850 A FR 8508850A FR 2565822 B1 FR2565822 B1 FR 2565822B1
Authority
FR
France
Prior art keywords
galenic form
new delayed
delayed
new
galenic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR858508850A
Other languages
English (en)
Other versions
FR2565822A1 (fr
Inventor
Wolfgang Czarnecki
Jean Claude Gfeller
Hans Peter Bier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of FR2565822A1 publication Critical patent/FR2565822A1/fr
Application granted granted Critical
Publication of FR2565822B1 publication Critical patent/FR2565822B1/fr
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2031—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FR858508850A 1984-06-14 1985-06-10 Nouvelle forme galenique retard Expired FR2565822B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3422083 1984-06-14
DE3442566 1984-11-22

Publications (2)

Publication Number Publication Date
FR2565822A1 FR2565822A1 (fr) 1985-12-20
FR2565822B1 true FR2565822B1 (fr) 1989-02-17

Family

ID=25822108

Family Applications (1)

Application Number Title Priority Date Filing Date
FR858508850A Expired FR2565822B1 (fr) 1984-06-14 1985-06-10 Nouvelle forme galenique retard

Country Status (21)

Country Link
AT (1) AT391806B (fr)
AU (2) AU587190B2 (fr)
BE (1) BE902626A (fr)
CA (1) CA1264441A (fr)
CY (1) CY1635A (fr)
DE (1) DE3520184C2 (fr)
DK (1) DK167649B1 (fr)
ES (1) ES8702141A1 (fr)
FR (1) FR2565822B1 (fr)
GB (3) GB2160100B (fr)
GR (1) GR851430B (fr)
HK (1) HK25192A (fr)
HU (1) HU198844B (fr)
IE (1) IE58834B1 (fr)
IL (1) IL75490A0 (fr)
IT (1) IT1200080B (fr)
LU (1) LU85946A1 (fr)
NL (1) NL194389C (fr)
NZ (1) NZ212390A (fr)
PT (1) PT80635B (fr)
SE (1) SE504583C2 (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1187751B (it) * 1985-10-15 1987-12-23 Eurand Spa Procedimento per la preparazione di formulazioni solidi di nifedipina ad elevata biodisponibilita' e ad effetto prolungato e formulazioni cosi' ottenute
US4816263A (en) * 1987-10-02 1989-03-28 Alza Corporation Dosage form for treating cardiovascular diseases comprising isradipine
AU3432689A (en) * 1988-03-24 1989-10-16 Bukh Meditec A/S Controlled release composition
GR1000270B (el) * 1988-09-30 1992-05-12 Alza Corp Μορφη δοσολογιας για θεραπεια καρδιαγγειακων ασθενειων.
DK469989D0 (da) * 1989-09-22 1989-09-22 Bukh Meditec Farmaceutisk praeparat
MX9300110A (es) * 1992-01-13 1994-07-29 Gerhard Gergely Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion.
DE4201179A1 (de) * 1992-01-17 1993-07-22 Alfatec Pharma Gmbh Wirkstoff(e) enthaltendes granulat oder pellet mit einem geruest aus hydrophilen makromolekuelen und verfahren zu seiner herstellung
US6726930B1 (en) 1993-09-09 2004-04-27 Penwest Pharmaceuticals Co. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5455046A (en) * 1993-09-09 1995-10-03 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems for insoluble drugs
US5773025A (en) 1993-09-09 1998-06-30 Edward Mendell Co., Inc. Sustained release heterodisperse hydrogel systems--amorphous drugs
GB2281697A (en) * 1993-09-14 1995-03-15 Euro Celtique Sa Laxative compositions in capsules
WO1998001117A1 (fr) 1996-07-08 1998-01-15 Edward Mendell Co., Inc. Matrice a liberation prolongee pour medicaments insolubles en doses elevees
DE19710009A1 (de) * 1997-03-12 1998-09-24 Knoll Ag Mehrphasige wirkstoffhaltige Zubereitungsformen
US6056977A (en) 1997-10-15 2000-05-02 Edward Mendell Co., Inc. Once-a-day controlled release sulfonylurea formulation
US6787157B1 (en) 1998-03-10 2004-09-07 Abbott Laboratories Multiphase active ingredient-containing formulations
US7001892B1 (en) 1999-06-11 2006-02-21 Purdue Research Foundation Pharmaceutical materials and methods for their preparation and use
EP1189599A2 (fr) * 1999-06-11 2002-03-27 Eli Lilly And Company Materiaux pharmaceutiques, leurs techniques de preparation et leurs utilisations
JP3462490B2 (ja) * 1999-08-04 2003-11-05 山之内製薬株式会社 安定な経口用医薬組成物
JP3893058B2 (ja) 1999-09-30 2007-03-14 ペンウェスト ファーマシューティカルズ カンパニー 高度に可溶性の薬物のための徐放性マトリックス系
BR0206825A (pt) * 2001-02-13 2004-02-25 Astrazeneca Ab Formulação de dispersão sólida de liberação modificada, multiparticulada, processo para a preparação da formulação, uso da mesma, tablete, e, métodos para o tratamento de uma doença cardiovascular, e, para o tratamento de câncer
US7135436B2 (en) 2003-05-05 2006-11-14 J.F. Daley International, Ltd. Solid algicide, preparation and usage in recirculating water
EP1690528A1 (fr) 2005-02-11 2006-08-16 Abbott GmbH & Co. KG Procedé pour la préparation des formes de dosage comprenant une dispersion solide d'un agent active microcristalline
JP2010511713A (ja) 2006-12-05 2010-04-15 ランデック コーポレイション 薬物送達
US8399007B2 (en) 2006-12-05 2013-03-19 Landec Corporation Method for formulating a controlled-release pharmaceutical formulation
US8114883B2 (en) 2007-12-04 2012-02-14 Landec Corporation Polymer formulations for delivery of bioactive materials
MX2011001864A (es) 2008-08-20 2011-06-20 Univ Texas Extrusion de fusion en caliente de multiples particulas de liberacion modificada.

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1617362A1 (de) * 1967-11-17 1971-03-25 Beiersdorf Ag Verfahren zur Herstellung von Arzneimitteln mit verzoegerter Wirkstoffabgabe in Form von Kapseln
DE2400819C2 (de) * 1974-01-09 1982-04-22 Bayer Ag, 5090 Leverkusen Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
DE2549740A1 (de) * 1975-11-17 1977-05-18 Sandoz Ag Neue galenische formen und verfahren zu deren herstellung
GB1579818A (en) * 1977-06-07 1980-11-26 Yamanouchi Pharma Co Ltd Nifedipine-containing solid preparation composition
CH639659A5 (de) * 1978-12-18 1983-11-30 Sandoz Ag Neue 1,4-dihydropyridinderivate, deren herstellung und verwendung.
DK149855C (da) * 1977-06-20 1987-04-21 Sandoz Ag Analogifremgangsmaade til fremstilling af 1,4-dihydropyridinderivater
EP0001247A1 (fr) * 1977-09-14 1979-04-04 Kanebo, Ltd. Composition pharmaceutique contenant de la nifédipine et procédé pour sa préparation.
WO1980001242A1 (fr) * 1978-12-21 1980-06-26 Sandoz Ag Preparations galeniques
DE2904310A1 (de) * 1979-02-05 1980-08-07 Boehringer Mannheim Gmbh Formlinge mit retardierter wirkstofffreisetzung und verfahren zu deren herstellung
JPS56115726A (en) * 1980-02-20 1981-09-11 Kaken Pharmaceut Co Ltd Pharmaceutical containing nifedipine
DE3033919A1 (de) * 1980-09-09 1982-04-22 Bayer Ag, 5090 Leverkusen Feste arzneizubereitungen enthaltend nifedipin und verfahren zu ihrer herstellung
US4442112A (en) * 1981-09-02 1984-04-10 Sandoz Ltd. Dihydropyridine derivatives useful in treating vascular headaches
DE3270785D1 (en) * 1981-10-29 1986-05-28 Bayer Ag Process for preparing solid fast-releasing drug formulations of dihydropyridines
CA1208558A (fr) * 1982-10-07 1986-07-29 Kazuo Kigasawa Medicament oral
DE3318649A1 (de) * 1983-05-21 1984-11-22 Bayer Ag, 5090 Leverkusen Zweiphasenformulierung

Also Published As

Publication number Publication date
BE902626A (fr) 1985-12-10
PT80635B (pt) 1987-10-20
IT1200080B (it) 1989-01-05
HK25192A (en) 1992-04-10
PT80635A (en) 1985-07-01
GB8514855D0 (en) 1985-07-17
FR2565822A1 (fr) 1985-12-20
LU85946A1 (fr) 1986-01-24
DK264785D0 (da) 1985-06-12
GB8727056D0 (en) 1987-12-23
DK264785A (da) 1985-12-15
GB8727055D0 (en) 1987-12-23
GB2196852A (en) 1988-05-11
GB2196852B (en) 1989-05-17
IT8548210A0 (it) 1985-06-13
GB2160100B (en) 1989-06-01
NZ212390A (en) 1992-02-25
SE504583C2 (sv) 1997-03-10
NL194389C (nl) 2002-03-04
DE3520184C2 (de) 1997-03-13
AT391806B (de) 1990-12-10
IE851460L (en) 1985-12-14
ATA174885A (de) 1990-06-15
ES544075A0 (es) 1987-01-01
AU4348685A (en) 1985-12-19
GR851430B (fr) 1985-11-25
CY1635A (en) 1992-11-06
ES8702141A1 (es) 1987-01-01
NL8501578A (nl) 1986-01-02
DK167649B1 (da) 1993-12-06
HUT40918A (en) 1987-03-30
AU587190B2 (en) 1989-08-10
GB2196851A (en) 1988-05-11
SE8502950L (sv) 1985-12-15
IE58834B1 (en) 1993-11-17
IL75490A0 (en) 1985-10-31
CA1264441A (fr) 1990-01-16
NL194389B (nl) 2001-11-01
SE8502950D0 (sv) 1985-06-13
DE3520184A1 (de) 1985-12-19
GB2196851B (en) 1989-06-07
GB2160100A (en) 1985-12-18
AU4454389A (en) 1990-03-22
HU198844B (en) 1989-12-28

Similar Documents

Publication Publication Date Title
FR2565822B1 (fr) Nouvelle forme galenique retard
DE3572358D1 (de) Thienyl condensed-pyrazole derivatives
DK35785A (da) Tetrahydrocarbazolonderivater
DK243985D0 (da) Aminoalkylphenoxyderivater
DE3463503D1 (de) Sulfonamido-benzamide derivatives
DK173785D0 (da) Phenylethanolaminderivater
DE3566887D1 (de) Flavanon derivatives
DK501085A (da) Substituerede benzimidazolderivater
DK524585A (da) Cholecalciferolderivater
DK460785D0 (da) Substituerede furanylderivater
DK443685D0 (da) Pirimidinderivater
DK320585A (da) Fluorallylaminderivater
DK333785A (da) Mevalonolactonderivater
DE3588103D1 (de) 5-Fluorouracil-Derivate
ES539508A0 (es) Derivados de androsteno nuevos
FI840579A0 (fi) Pipett med reglerbar volym
DK514585D0 (da) Aminoethylanilinderivater
IT1184934B (it) Laminatoio
DE3565100D1 (de) Cycloalkane-indene-carboximidamide derivatives
DK267190D0 (da) 13-substitueret-5-ketomilbemycinderivater
DK54085D0 (da) Phenylpropargylaminderivater
ZA854520B (en) Novel galenic retard form
FI840975A0 (fi) Amalgamlegeringar med laog silverhalt foer anvaendning vid tandvaord
FR2568253B1 (fr) Nouvelle amidine
FI840275A0 (fi) Blankett

Legal Events

Date Code Title Description
TP Transmission of property